doi: 10.1155/2023/9812108.
eCollection 2023.
Retracted: Biomarkers for Breast Adenocarcinoma Using In Silico Approaches
- PMID: 37593034
- PMCID: PMC10432112
- DOI: 10.1155/2023/9812108
Item in Clipboard
Retracted: Biomarkers for Breast Adenocarcinoma Using In Silico Approaches
Evid Based Complement Alternat Med.
.
Abstract
[This retracts the article DOI: 10.1155/2022/7825272.].
Copyright © 2023 Evidence-Based Complementary and Alternative Medicine.
Retraction of
-
Biomarkers for Breast Adenocarcinoma Using In Silico Approaches.Evid Based Complement Alternat Med. 2022 Mar 3;2022:7825272. doi: 10.1155/2022/7825272. eCollection 2022. Evid Based Complement Alternat Med. 2022. Retraction in: Evid Based Complement Alternat Med. 2023 Aug 9;2023:9812108. doi: 10.1155/2023/9812108. PMID: 35280505 Free PMC article. Retracted.
Similar articles
-
Retracted: Protumor Effects of Histone H3-H4 Chaperone Antisilencing Feature 1B Gene on Lung Adenocarcinoma: In Silico and In Vitro Analyses.Comput Math Methods Med. 2023 Dec 6;2023:9861394. doi: 10.1155/2023/9861394. eCollection 2023. Comput Math Methods Med. 2023. PMID: 38094420 Free PMC article.
-
Retracted: In Silico Identification of Hub Genes as Observing Biomarkers for Gastric Cancer Metastasis.Evid Based Complement Alternat Med. 2023 Aug 9;2023:9780939. doi: 10.1155/2023/9780939. eCollection 2023. Evid Based Complement Alternat Med. 2023. PMID: 37593028 Free PMC article.
-
Retracted: Identification of Cigarette Smoking-Related Novel Biomarkers in Lung Adenocarcinoma.Biomed Res Int. 2024 Mar 20;2024:9824073. doi: 10.1155/2024/9824073. eCollection 2024. Biomed Res Int. 2024. PMID: 38550135 Free PMC article.
-
Retracted: Chemical Composition and Biological Evaluation of Typha domingensis Pers. to Ameliorate Health Pathologies: In Vitro and In Silico Approaches.Biomed Res Int. 2024 Jan 9;2024:9840785. doi: 10.1155/2024/9840785. eCollection 2024. Biomed Res Int. 2024. PMID: 38230122 Free PMC article.
-
Retracted: Novel Prognostic Biomarkers for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Patients via Analysis of Competing Endogenous RNA (ceRNA) Network.Dis Markers. 2023 Jul 26;2023:9841329. doi: 10.1155/2023/9841329. eCollection 2023. Dis Markers. 2023. PMID: 37538089 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
